miR-484 acts as an "oncomiR" in triple negative breast cancer cells to promote tumor growth and progression by targeting HOXA5

被引：0
|
作者：
Kabil, Nashwa N. [1 ]
Bayraktar, Recep [1 ]
Ivan, Cristina [1 ]
Kahraman, Nermin [1 ]
Mokhlis, Hamada A. [1 ]
Calin, George A. [1 ]
Lopez-Berestein, Gabriel [1 ]
Ozpolat, Bulent [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-504
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
504
引用
收藏
页数：2
相关论文
共 50 条
  • [1] OncomiR and tumor-suppressor miR expression in triple-negative primary breast cancer
    Radojicic, Jelena
    Zaravinos, Apostolos
    Vrekoussis, Thomas
    Kafousi, Maria
    Spandidos, Demetrios A.
    Stathopoulos, Efstathios N.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2011, 28 : S66 - S66
  • [2] miR-374a-5p induces tumor progression in triple negative breast cancer
    Kim, Yesol
    Son, Dasom
    Kim, Do Yeon
    Park, Jong Hoon
    CANCER RESEARCH, 2019, 79 (13)
  • [3] MiR-301b-3p Promotes the Occurrence and Development of Breast Cancer Cells via Targeting HOXA5
    Lu, Xianqiu
    Duan, Jianwen
    Zhou, Rui
    Xu, Yufen
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2021, 31 (03): : 35 - 44
  • [4] miR-374a-5p promotes tumor progression by targeting ARRB1 in triple negative breast cancer
    Son, Dasom
    Kim, Yesol
    Lim, Sera
    Kang, Hyeok-Gu
    Kim, Da-Hyun
    Park, Jee Won
    Cheong, Woosung
    Kong, Hyun Kyung
    Han, Wonshik
    Park, Woong-Yang
    Chun, Kyung-Hee
    Park, Jong Hoon
    CANCER LETTERS, 2019, 454 : 224 - 233
  • [5] Tumor-associated glycans as key molecules to promote growth of triple-negative breast cancer cells
    Lida, J.
    Dorchak, J.
    Clancy, R.
    Slavik, J.
    Cutler, M. L.
    Shriver, C. D.
    CANCER RESEARCH, 2016, 76
  • [6] Hsa-miR-105-5p acts as an oncogene in triple-negative breast cancer
    Qian, Da
    Zhou, Tao
    Xiong, Hanchu
    Xu, Yuhao
    Qiu, Jie
    Wu, Yihao
    Hong, Weimin
    Meng, Xuli
    CHINESE MEDICAL JOURNAL, 2023, 136 (24) : 3022 - 3024
  • [7] Hsa-miR-105-5p acts as an oncogene in triple-negative breast cancer
    Qian Da
    Zhou Tao
    Xiong Hanchu
    Xu Yuhao
    Qiu Jie
    Wu Yihao
    Hong Weimin
    Meng Xuli
    中华医学杂志英文版, 2023, 136 (24)
  • [8] Targeting Tumor Initiating Cells with siRNA/Nanotherapy in Triple Negative Breast Cancer.
    Granados-Principal, S.
    Deng, X.
    Liu, D.
    Chang, J. C.
    Shen, H.
    Dave, B.
    CANCER RESEARCH, 2011, 71
  • [9] lncRNA GSEC Promotes the Progression of Triple Negative Breast Cancer (TNBC) by Targeting the miR-202-5p/AXL Axis
    Zhang, Jianhua
    Du, Chuang
    Zhang, Linfeng
    Wang, Yan
    Zhang, Yingying
    Li, Jingruo
    ONCOTARGETS AND THERAPY, 2021, 14 : 2747 - 2759
  • [10] miR-539 acts as a tumor suppressor by targeting epidermal growth factor receptor in breast cancer
    Guo, Jilong
    Gong, Guohua
    Zhang, Bin
    SCIENTIFIC REPORTS, 2018, 8
12345